Atlas Trials

TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection

Clinical trial NCT01983579 · TERMINATED

Trial details

NCT number
NCT01983579
Sponsor
Sensimed AG
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Neovascular Age Related Macular Degeneration (AMD)Open Angle Glaucoma
Start date
2013-10-01
Primary completion
2014-02-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.